Africa: Prevail Part of Large Ebola Vaccine Study Conducted in West Africa That Publishes Promising Findings

[FrontPageAfrica] Monrovia — The Partnership for Research on Vaccines and Infectious Diseases in Liberia (PREVAIL), a joint Liberia-United States clinical research partnership, is part of the Partnership for Research on Ebola Vaccinations (PREVAC), an international consortium that conducts research in West Africa. The PREVAC consortium (Liberia, Guinea, Mali, and Sierra Leone) includes scientists from PREVAIL, the French research organization Inserm, and from institutions in Africa, the United States, and the United Kingdom. The conso